Princeton, NJ, United States of America

Richard Berger


 

Average Co-Inventor Count = 7.6

ph-index = 7

Forward Citations = 124(Granted Patents)


Location History:

  • Cranford, NJ (US) (2003 - 2007)
  • Princeton, NJ (US) (2010 - 2014)
  • Perkasie, PA (US) (2014)
  • Harleysville, NJ (US) (2020)
  • Harleysville, PA (US) (2017 - 2021)

Company Filing History:


Years Active: 2003-2021

Loading Chart...
Loading Chart...
19 patents (USPTO):

Title: Inventor Spotlight: Richard Berger - Pioneering Innovations in Pharmaceutical Research

Introduction:

Richard Berger, a distinguished inventor based in Princeton, NJ, has made significant contributions to the field of pharmaceutical research with his groundbreaking inventions. With a total of 19 patents to his name, Berger's work has focused on developing novel compounds to combat a range of diseases, from cancer to neurodegenerative disorders.

Latest Patents:

Berger's latest patents showcase his expertise in designing compounds with promising therapeutic potential:

1. "3-aryl-heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (HDAC6) inhibitors": Berger's invention of substituted 5-trifluoromethyl oxadiazole compounds aims to treat cellular proliferative diseases, including cancer and neurodegenerative conditions like schizophrenia and stroke.

2. "Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitors": Berger's innovative pyrimidine carboxamide compounds target central nervous system disorders associated with PDE2, offering new possibilities for treating conditions such as schizophrenia and Parkinson's disease.

Career Highlights:

Throughout his career, Richard Berger has held key positions at reputable companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Merck & Company, Inc. His tenure at these organizations has allowed him to translate his inventive ideas into tangible solutions that have the potential to improve patient outcomes worldwide.

Collaborations:

Berger's collaborative spirit has been instrumental in bringing his inventions to fruition. Working alongside accomplished professionals such as Scott D Edmondson and Cheng Zhu, Berger has leveraged collective expertise to drive innovation and advance the boundaries of pharmaceutical research.

Conclusion:

In conclusion, Richard Berger stands out as a visionary inventor whose passion for discovery has led to the creation of impactful pharmaceutical compounds. His relentless pursuit of novel solutions for complex diseases underscores his commitment to making a difference in the field of healthcare. Berger's groundbreaking work continues to inspire and shape the future of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…